Trademark: 90750514
Word
LAGUNA CLINICAL RESEARCH ASSOCIATES
Status
Registered
Status Code
700
Status Date
Tuesday, June 20, 2023
Serial Number
90750514
Registration Number
7082981
Registration Date
Tuesday, June 20, 2023
Mark Type
3000
Filing Date
Wednesday, June 2, 2021
Published for Opposition
Tuesday, April 4, 2023

Trademark Owner History

Classifications
42 Clinical research in the nature of conducting medical clinical trials for others
The mark consists of the stylized word "LAGUNA" with a horizontal line underneath and the words "CLINICAL RESEARCH ASSOCIATES" under the line all to the right of an overlapping pinwheel design consisting of circles.
"CLINICAL RESEARCH ASSOCIATES"

Trademark Events
Jun 20, 2023
Notice Of Registration Confirmation Emailed
Jun 20, 2023
Registered-Principal Register
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 24, 2023
Approved For Pub - Principal Register
Jan 19, 2023
Teas/Email Correspondence Entered
Jan 18, 2023
Correspondence Received In Law Office
Jan 18, 2023
Teas Response To Office Action Received
Dec 8, 2022
Notification Of Non-Final Action E-Mailed
Dec 8, 2022
Non-Final Action E-Mailed
Dec 8, 2022
Non-Final Action Written
Nov 9, 2022
Teas/Email Correspondence Entered
Nov 8, 2022
Correspondence Received In Law Office
Nov 8, 2022
Teas Response To Office Action Received
May 16, 2022
Notification Of Non-Final Action E-Mailed
May 16, 2022
Non-Final Action E-Mailed
May 16, 2022
Non-Final Action Written
Mar 30, 2022
Teas/Email Correspondence Entered
Mar 29, 2022
Correspondence Received In Law Office
Mar 29, 2022
Teas Response To Office Action Received
Mar 7, 2022
Notification Of Non-Final Action E-Mailed
Mar 7, 2022
Non-Final Action E-Mailed
Mar 7, 2022
Non-Final Action Written
Feb 16, 2022
Assigned To Examiner
Aug 26, 2021
Notice Of Design Search Code E-Mailed
Aug 25, 2021
New Application Office Supplied Data Entered
Jun 5, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24